Amato Otani

Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate

Itsuki Osawa, Koh Okamoto, Mahoko Ikeda et al. · Journal of Thrombosis and Thrombolysis · 2020 · 25 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +9

Hepatitis B Virus Reactivation After Switch to Cabotegravir/Rilpivirine in Patient with Low Hepatitis B Surface Antibody

Eisuke Adachi, Ayako Sedohara, Kotaro Arizono et al. · Emerging infectious diseases · 2024 · 19 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

The association between adverse reactions and immune response against SARS-CoV-2 spike protein after vaccination with BNT162b2 among healthcare workers in a single healthcare system: a prospective observational cohort study

Daisuke Jubishi, Koh Okamoto, Kensuke Hamada et al. · Human Vaccines & Immunotherapeutics · 2022 · 18 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia

Mahoko Ikeda, Shu Okugawa, Kosuke Kashiwabara et al. · International Journal of Infectious Diseases · 2023 · 18 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Favorable Virological Outcome, Characteristics of Injection Site Reactions, Decrease in Renal Function Biomarkers in Asian People with HIV Receiving Long-Acting Cabotegravir Plus Rilpivirine

Eisuke Adachi, Makoto Saito, Amato Otani et al. · AIDS Research and Human Retroviruses · 2024 · 17 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17